MANHARD KIMBERLY 4
4 · HERON THERAPEUTICS, INC. /DE/ · Filed Jan 17, 2023
Insider Transaction Report
Form 4
MANHARD KIMBERLY
Director
Transactions
- Other
Common Stock
2022-10-31$3.27/sh+1,655$5,416→ 20,131 total - Tax Payment
Common Stock
2023-01-13$3.17/sh−2,012$6,378→ 23,933 total - Exercise/Conversion
Restricted Stock Units
2023-01-13−1,250→ 8,750 total→ Common Stock (1,250 underlying) - Exercise/Conversion
Common Stock
2023-01-13+4,564→ 25,945 total - Exercise/Conversion
Common Stock
2023-01-13+1,250→ 21,381 total - Exercise/Conversion
Restricted Stock Units
2023-01-13−4,564→ 32,500 total→ Common Stock (4,564 underlying)
Footnotes (5)
- [F1]Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2022.
- [F2]Restricted stock units convert into common stock on a one-for-one basis.
- [F3]Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
- [F4]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).
- [F5]The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).